ArticleTransgender health2025
Metoidioplasty and Phalloplasty Gender-Affirming Surgery and Association with Gender Congruence and Life Satisfaction: A Cross-Sectional Study.
Article in Transgender health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Evaluating quality, understandability, and actionability of YouTube content for gender-affirming surgery.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025Article
- Current directions in research on patient experiences of metoidioplasty and phalloplasty.International journal of transgender health · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: The purpose of this study was to compare the Gender Congruence and Life Satisfaction (GCLS) Scale scores between transgender men and nonbinary individuals assigned female at birth who have had metoidioplasty and phalloplasty gender-affirming surgery (MaPGAS) versus those who have not. Methods: We conducted a national cross-sectional survey of individuals considering or post-MaPGAS recruited through social media and a community health center. Data collected included demographics, medical health history, and GCLS scale scores. GCLS scale items evaluate gender congruence across psychological, physical, quality of life, genital, chest, and social domains on a 1-5 Likert scale, with higher values indicating greater gender congruence. The mean GCLS total and subscale scores were compared between groups, and open-ended comments related to gender, mental well-being, and life satisfaction were thematically analyzed. Results: A total of 326 participants, mean age 29.9 years (standard deviation 8.8), identifying primarily as transgender male ( Conclusion: In this cohort of individuals considering MaPGAS, individuals post-MaPGAS demonstrated higher GCLS scale scores. Individuals post-phalloplasty reported the highest overall GCLS score and majority subscale scores.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.